Tuesday, November 18, 2008: 8:55 AM
Room 109-B (Pennsylvania Convention Center)
Since 2006, teams from Novartis Pharmaceuticals Corp. and the FDA's Division of Product Quality Research have been collaborating through a Cooperative Research and Development Agreement (CRADA) on the implementation of Quality by Design principles to the API and Drug Product manufacturing processes of a commercial product. This presentation will therefore consist of case studies extracted from this pilot project and will also highlight the key lessons learned.
See more of this Session: Quality by Design- Invited Talks and Round Table Discussion
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
![[ Visit Client Website ]](images/banner.gif)